Gemcitabine plus cisplatin combination given with amifostine (GAP) to heavily pretreated patients with gynecologic and peritoneal cancers: tolerance and activity in ovarian cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/9877238

Download in:

View as

General Info

PMID
9877238